Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Poillon DianeDirector |  BHRBBurke & Herbert Financial Services Corp.Grant or award | A | — 675 sh | May 1, 2026 |
| 9 | Snyder KristenDirector | BHRBBurke & Herbert Financial Services Corp. Grant or award | A | — 8,418 sh | May 1, 2026 traded May 1, 2026 |
| 9 | Griffiths SimonCEO |  CACCAMDEN NATIONAL CORPTax withholding | F | $37K 776 sh | May 1, 2026 traded Apr 30, 2026 |
| 9 | Fu LuyangSr. VP, Chief Actuary - Sub |  CINFCINCINNATI FINANCIAL CORPOption exercise | M | — 957 sh | May 1, 2026 traded Apr 29, 2026 |
| 9 | Baker JeffPrincipal Accounting Officer | CRWVCoreWeave, Inc. Option exercise | M | — 12.5K sh | May 1, 2026 traded Apr 29, 2026 |
| 9 | McKinney SamanthaDirector |  CHRDChord Energy CorpGrant or award | A | — 1,524 sh | May 1, 2026 traded Apr 29, 2026 |
| 9 | Guerre Robert PaulSec, Dir of Corp Compliance |  UFPIUFP INDUSTRIES INCGrant or award | A | $1,432 16 sh | May 1, 2026 traded Apr 30, 2026 |
| 9 | Lawver Teri LDirector |  ALTAltimmune, Inc.Grant or award | A | — 48.8K sh | May 1, 2026 traded May 1, 2026 |
| 9 | Forbes AndrewEVP | CACCAMDEN NATIONAL CORP Tax withholding | F | $4,672 97 sh | May 1, 2026 traded Apr 30, 2026 |
| 9 | McKnight GarrettEVP | CACCAMDEN NATIONAL CORP Tax withholding | F | $5,058 105 sh | May 1, 2026 traded Apr 30, 2026 |
| 9 | Forbes AndrewEVP | CACCAMDEN NATIONAL CORP Tax withholding | F | $6,092 127 sh | May 1, 2026 traded Apr 29, 2026 |
| 9 | Sharma PankajChief Business Officer |  RELYRemitly Global, Inc.Grant or award | A | — 118.4K sh | May 1, 2026 traded Apr 29, 2026 |
| 9 | Martel William HEVP | CACCAMDEN NATIONAL CORP Tax withholding | F | $7,579 158 sh | May 1, 2026 traded Apr 29, 2026 |
| 9 | Gonzalez Herrera Jesus VicentePresident of Cemex USA |  CXCEMEX SAB DE CVGrant or award | A | — 73.6K sh | May 1, 2026 traded May 1, 2026 |
| 9 | Weakley MonicaDirector |  EXPIAGNT, Inc.Option exercise | M | — 320 sh | May 1, 2026 traded Apr 30, 2026 |
| 9 | Paulson JohnDirector |  BLCOBausch & Lomb CorpGrant or award | A | $22K 1,375 sh | May 1, 2026 traded Apr 30, 2026 |
| 9 | Smith Ryan AEVP | CACCAMDEN NATIONAL CORP Tax withholding | F | $6,647 138 sh | May 1, 2026 traded Apr 30, 2026 |
| 9 | Archer Michael REVP | CACCAMDEN NATIONAL CORP Tax withholding | F | $8,826 184 sh | May 1, 2026 traded Apr 29, 2026 |
| 9 | Miller Michael FrancisChief Operating Officer | QTRXQuanterix Corp Option exercise | M | — 130 sh | May 1, 2026 traded Apr 30, 2026 |
| 9 | Ackley DavidEVP | CACCAMDEN NATIONAL CORP Tax withholding | F | $5,299 110 sh | May 1, 2026 traded Apr 30, 2026 |
| 8 | Gahlhoff Jerry Jr.Director, PRESIDENT & CEO |  ROLROLLINS INCGift | G | — 3,629 sh | May 1, 2026 traded Apr 29, 2026 |
| 8 | Wassil JimCHIEF OPERATING OFFICER |  PCVXVaxcyte, Inc.Open-market sale · 10b5-1 plan | SELL | $128K 2,250 sh | May 1, 2026 traded May 1, 2026 |
| 8 | Sloan SheldonChief Medical Officer |  SYRESpyre Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $2.15M 78.3K sh | May 1, 2026 traded May 1, 2026 |
| 7 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 78.3K sh | May 1, 2026 traded May 1, 2026 |
| 7 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $78K 7,500 sh | May 1, 2026 traded Apr 29, 2026 |
| 6 | Burrows Scott LChief Financial Officer | SYRESpyre Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $181K 12.5K sh | May 1, 2026 traded May 1, 2026 |
| 5 | Hardy AndrewEVP, Chief Sales Officer |  NXPINXP Semiconductors N.V.Option exercise | M | — 4,880 sh | May 1, 2026 traded Apr 30, 2026 |
| 5 | Stangl RolfDirector |  REYNReynolds Consumer Products Inc.Grant or award | A | — 10.7K sh | May 1, 2026 traded Apr 29, 2026 |
| 5 | Page Andrew EChief Financial Officer |  ASAmer Sports, Inc.Grant or award | A | — 30.4K sh | May 1, 2026 traded May 1, 2026 |
| 5 | Sharma PankajChief Business Officer | RELYRemitly Global, Inc. Grant or award | A | — 15.3K sh | May 1, 2026 traded Apr 29, 2026 |
| 5 | Flees Lori AnnDirector, President & CEO |  VVVVALVOLINE INCGrant or award | A | $1,927 58 sh | May 1, 2026 traded Apr 30, 2026 |
| 5 | Karlsson Jutta CGeneral Counsel | ASAmer Sports, Inc. Grant or award | A | — 5,180 sh | May 1, 2026 traded May 1, 2026 |
| 4 | Hamilton Brian TDirector, President of CCBX |  CCBCOASTAL FINANCIAL CORPOpen-market sale · 10b5-1 plan | SELL | $232K 3,079 sh | May 1, 2026 traded May 1, 2026 |
| 4 | Aoki IchiroDirector, President |  INDIindie Semiconductor, Inc.Option exercise · 10b5-1 plan | M | — 100.0K sh | May 1, 2026 traded Apr 30, 2026 |
| 2 | Feeley KevinCHIEF FINANCIAL OFFICER |  WGSGeneDx Holdings Corp.Option exercise | M | — 754 sh | May 1, 2026 traded Apr 29, 2026 |
| 2 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 754 sh | May 1, 2026 traded Apr 29, 2026 |
| 1 | Shafer AndrewChief Cust Mkt & Brnd Officer |  GEVOGevo, Inc.Open-market sale · 10b5-1 plan | SELL | $11K 5,550 sh | May 1, 2026 traded May 1, 2026 |
| 0 | Aoki IchiroDirector, President | INDIindie Semiconductor, Inc. Option exercise · 10b5-1 plan | M | — 100.0K sh | May 1, 2026 traded Apr 30, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 61.5K sh | May 1, 2026 traded Apr 29, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 15.4K sh | May 1, 2026 traded Apr 29, 2026 |